ReviewInternational journal of molecular sciences2018

CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS).

Ewa Kruminis-Kaszkiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.